An overview of genetic factors influencing plasma lipid levels and coronary artery disease risk

Archives of Pathology and Laboratory Medicine

Volumn 123, Issue 12, 1999, Pages 1219-1222

  Cetin Ozturk, I ^a   Killeen, Anthony A ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B100; APOLIPOPROTEIN E; CHOLESTEROL ESTER TRANSFER PROTEIN; LIPOPROTEIN A; LIPOPROTEIN LIPASE; LOW DENSITY LIPOPROTEIN RECEPTOR; PHOSPHATIDYLCHOLINE STEROL ACYLTRANSFERASE;

ARTICLE; CORONARY ARTERY DISEASE; GENE LOCUS; GENETIC RISK; HUMAN; HUMAN CELL; HUMAN TISSUE; LIPID BLOOD LEVEL; POPULATION RISK; RISK FACTOR;

APOLIPOPROTEIN B-100; APOLIPOPROTEIN C-II; APOLIPOPROTEINS B; APOLIPOPROTEINS C; APOLIPOPROTEINS E; CARRIER PROTEINS; CHOLESTEROL ESTER TRANSFER PROTEINS; CORONARY DISEASE; GLYCOPROTEINS; HUMANS; LIPIDS; LIPOPROTEIN LIPASE; LIPOPROTEIN(A); LIPOPROTEINS, HDL; RECEPTORS, LDL;

EID: 13044304197     PISSN: 00039985     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Rosamond WD, Chaambeless LE, Folsom AR, et al. Trends in the incidence of myocardial infarction and in mortality due to coronary heart disease, 1987-1994. N Engl J Med. 1998;339:861-867.
2. Braunwald E. Cardiovascular medicine at the turn of the millennium: triumphs, concerns, and opportunities. N Engl J Med. 1997;337:1360-1369.
3. Bittner V. Atherosclerosis and the immune system. Arch Intern Med. 1998;158:1395-1396.
4. Humphries SE, Peacock RE, Talmud PJ. The genetic determinants of plasma cholesterol and response to diet. Baillieres din Endocrinol Metab. 1995;9:797-823.
5. Rath M, Niendorf A, Reblin T, Dietel M, Krebber HJ, Beisigel U. Detection and quantification of lipoprotein(a) in the arterial wall of 107 coronary bypass patients. Arteriosclerosis. 1989;9:579-592.
6. Santamarina-Fojo S. The familial chylomicronemia syndrome. Endocrinol Metab Clin North Am. 1998;27:551-567.
7. Monsalve MV, Henderson H, Roederer G, et al. A missense mutation at codon 188 of the human lipoprotein lipase gene is a frequent cause of lipoprotein lipase deficiency in persons of different ancestries. J Clin Invest. 1990;86:728-734.
8. Wittrup HH, Tybjaerg-Hansen A, Abildgaard S, Steffensen R, Schnohr P, Nordestgaard BG. A common substitution (asn291 ser) in lipoprotein lipase is associated with increased risk of ischemic heart disease. J Clin Invest. 1997;99:1606-1613.
9. Kuivenhoven JA, Jukema JW, Zwinderman AH, et al. The role of a common variant of the cholesteryl ester transfer protein gene in the progression of coronary atherosclerosis. N Engl J Med. 1998;338:86-93.
10. Gordon T, Castelli WP, Hjortland MC, Kannel WB, Dawber TR. High-density lipoprotein as a protective factor against coronary heart disease. Am J Med. 1977:62:707-714.
11. Breslow J. Familial disorders of high-density lipoprotein metabolism. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The metabolic and molecular basis of inherited disease. 7th ed. New York, NY: McGraw Hill; 1995:2031-2052.
12. Franceschini G, Sirtori CR, Capurso A, et al. A-I Milano apoprotein: decreased high-density lipoprotein cholesterol levels with significant lipoprotein modifications and without clinical atherosclerosis in an Italian family. J Clin Invest. 1980;66:892.